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Abstract 
We have cloned a cDNA for a novel member of the opioid receptor family, designated as ROR-C, from the rat cerebrum cDNA library using 
the probe derived from the dopioid receptor subtype cDNA. The deduced amino acid sequence of ROR-C shows high homology with those of ROR-A 
(rat S-opioid receptor subtype), ROR-B (rat ,&subtype) and ROR-D (rat K-subtype). RNA blot hybridization and in situ hybridization analysis 
revealed that ROR-C mRNA is expressed in discrete regions of the rat centraf nervous system. 
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1. Introduction 
G-protein-coupled receptors constitute essential com- 
ponents of the signalling systems in nervous systems [I]. 
A growing number of G-protein-coupled receptors have 
been identified by means of recombinant DNA technol- 
ogy [Z]. Recently, primary structures of the ,u-, 6- and 
E-opioid receptor subtypes, that were known to mediate 
a variety of cellular responses through the action of G- 
proteins [3], have been elucidated by cloning and se- 
quencing the cDNAs [4-163. Analysis of the deduced 
amino acid sequences howed that these opioid receptor 
subtypes possess characteristic structural features of G- 
protein-coupled receptors and have -60% ammo acid se- 
quence identity to each other. 
This investigation deals with cloning and sequencing 
a cDNA, designated as ROR-C, from rat cerebrum 
cDNA library by cross-hybridization using the &opioid 
receptor subtype cDNA as a probe. The results obtained 
suggest hat ROR-C represents a novel member of the 
opioid receptor family with a high degree of ammo acid 
sequence homology to the so far cloned opioid receptors. 
However, ligand-binding studies demonstrated no spe- 
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cific binding of opioid ligands or sigma ligands to mem- 
branes prepared from COS-7 cells transfected with the 
ROR-C cDNA. RNA blot hybridization and in situ hy- 
bridization analysis using rat brain tissues showed that 
hypothalamus and brainstem contain ROR-C mRNA in 
discrete cell groups. These results suggest hat ROR-C 
may be involved in the modulation of ne~otrans~ssion 
in the noradrenergic system and/or in the regulation of 
the autonomic nervous system and the neuroendocrine 
system. 
2. Materials and methods 
2.1. Cloning of cDNA 
A rat cerebrum cDNA library was screened with the mouse Sopioid 
receptor subtype cDNA probe as in [8,10]. cDNA inserts of three clones 
including pROR13 and pROR30 share a common restriction endonu- 
clease map (SacI, PstI, SmaI and A@) different from those of ROR-A 
(&-subtype), ROR-B @-subtype) and ROR-D (K-subtype), and are indi- 
cated to be derived from identical mRNA species (ROR-C). pROR13 
and pROR30, carrying the entire pro~in~~rng sequence of ROR-C, 
were used for sequence analysis f17,18]. 
2.2. Expression of cDNA and Iigand-binding assay 
The - 1.7-kilobase pairs (kbp) HindIiI fragment from pROR30, con- 
taining the entire protein-coding sequence of ROR-C, was cloned into 
the Hind111 site of an expression plasmid pKCRH2 [19] in the same 
orientation with respect o SV40 promoter to yield pRORS30-2. The 
-4.2-kbp Sac1 fragment from pROR13 was blunted with T., DNA 
polymerase and ligated with the synthetic Hind111 linkers to yield 
pRORS13-1. The -1.2.kbp Hind111 fragment from pRORS13-1 was 
cloned into the H&d111 site of pKCRH2 in the same orientation with 
All rights reserved. 
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respect o SV40 promoter to yield pRORS13-3. COS-7 cells were trans- 
fected [20] with pRORS30-2 or pRORS13-3 and harvested after 2-3 
days. Crude membranes were prepared and assayed for ligand binding 
as in [&lo]. 
2.3. RNA blot hybridization analysis 
Total RNA and poly(A)+ RNA prepared from tissues of adult Wistar 
rats were analyzed as in [S,lO]. The hybridization probe used was the 
-1.dkbp cDNA insert of pROR30. The probe was labelled with 
[a-32P]dCTP by the random primer method [21]. Autoradiography was 
performed at -80°C for 9 days with an intensifying screen. An RNA 
ladder (Bethesda Research Laboratories) and the Hind111 cleavage 
products of phage jl DNA were used as size markers. 
2.4. In situ hybridization analysis 
The -1.3-kbp EcoRI fragment from pROR13 was cloned into 
pBluescript SK(-) to yield pRORS13-4. Sense or antisense riboprobe 
RNA was synthesized in vitro in the presence of digoxigenin-1 1-UTP, 
using BumHI- or EcoRV-cleaved pRORS13-4 as a template, respec- 
tively. Under intraperitoneal pentobarbital anesthesia, dult male Spra- 
gue-Dawley rats were perfused transcardially with a fixative consisted 
of 4% pamformaldehyde and 0.12 M sodium phosphate (PH 7.3). The 
brains were soaked overnight in a solution containing 30% sucrose and 
0.12 M sodium phosphate @H 7.3), and cut into coronal sections of 
50-pm thickness on a freezing microtome. Free-floating sections were 
treated with hydrochloric acid, Triton X-100 and proteinase K, and 
incubated with the hybridization solution (50% deionized formamide/ 
0.75 M NaCV25 mM EDTA/25 mM PIPES/O.Z% SDS/l x Denhardt’s 
solutionl25Opg . ml-’ salmon sperm DNA/250pg. ml-’ yeast RNA/48 
dextran sulfate) for 1 h. Hybridization was carried out overnight at 
55°C in the hybridization solution added with 1 ng . ~1~’ digoxigenin- 
labelled riboprobe. Hybridized sections were then rinsed in 4x, 2x, lx 
and 0.5x standard saline citrate (SSC), RNase A was added, and finally 
washed with 0. lx SSC. The sections were incubated with alkaline phos- 
phatase-conjugated anti-digoxigenin antibody (1:200 dilution; Boehrin- 
ger-Mannheim) and reacted with chromogenic substrates, 5-bromo-4- 
chloro-3-indolylphosphate and nitroblue tetrazolium. They were then 
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placed onto gelatin-coated glass slides, dried and embedded in Crystal- 
mount. 
3. Results 
cDNA library derived from rat cerebrum poly(A)’ 
RNA was screened by hybridization with a DNA frag- 
ment comprising a part of the mouse S-opioid receptor 
subtype cDNA [4,5]. A novel class of cDNA clones 
(ROR-C) was isolated and nucleotide sequence analysis 
revealed an open reading frame of 1,101 nucleotides en- 
coding a sequence of 367 amino acids. Fig. 1 shows the 
deduced amino acid sequence of the ROR-C protein 
aligned with those of ROR-A (rat &opioid receptor sub- 
type), ROR-B (rat p-subtype) and ROR-D (rat rc-sub- 
type). Amino acid sequence comparison reveals 53%, 
52% and 51% identity between ROR-C/ROR-A, ROR- 
C/ROR-B and ROR-C/ROR-D pairs, respectively. The 
ROR-C molecule shares characteristic structural fea- 
tures with G-protein-coupled receptors [2]. Seven trans- 
membrane segments are predicted in the ROR-C mole- 
cule, and three consensus N-glycosylation sites [22] occur 
in the amino-terminal region preceding the predicted 
transmembrane segment, TM-I. Furthermore, the car- 
boxy-terminal region just following TM-VII contains 
two conserved cysteine residues that may be modified by 
pahnitoylation [2]. To establish evolutionary relation- 
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Fig. 1. Deduced amino acid sequence of ROR-C (first line) and its alignment with those of ROR-A (rat S-opioid receptor subtype) (second line), 
ROR-B (rat ,u-subtype) (third line) and ROR-D (rat rc-subtype) (fourth line). Sequence data for ROR-A, ROR-B and ROR-D have been taken from 
[8,10]. The one-letter amino acid notation is used. Gaps (-) have been inserted to achieve maximum homology. Amino acid residues are numbered 
from the initiating methionine and numbers of the residues at the right-hand end of the individual lines are given. The predicted transmembrane 
segments (TM-I-VII) are indicated; the termini of each segment are tentatively assigned. The nucleotide sequence of ROR-C appears in the DDBJ, 
EMBL and GenBank Nucleotide Sequence Databases under the accession umber D16438. 
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Fig. 2. Phylogenetic tree of the opioid receptors and the somatostatin 
receptors. On the basis of the distance matrix between aligned amino 
acid sequences, the tree was inferred by the neighbor-joining method 
[23]. The deepest root was determined by including distantly related 
subfamilies in comparison. Branch lengths are proportional to the num- 
bers of amino acid substitutions. The number at each branching point 
indicates the bootstrap probability that two lineages are joined together 
to form a single cluster [27]. The members of the somatostatin receptor 
family included in this analysis are human SSTRl [28], human SSTRZ 
[28], human SSTR3 [29], human SSTR4 [30,31] and human SSTRS [31]. 
ships among ROR-A-D and the somatostatin receptors, 
which show the highest degree of homology to the opioid 
receptors among the G-protein-coupled receptors 
[5,7,12,15,16], a phylogenetic tree was constructed by the 
neighbor-joining method [23] (Fig. 2). The phylogenetic 
tree shows that the opioid receptor family forms a single 
cluster which is separated from the cluster of the somato- 
statin receptor family. Judging from the bootstrap prob- 
ability between lineages leading to ROR-C and three 
other RORs, it is highly likely that ROR-C is included 
in the cluster of the opioid receptor family and thus is a 
novel member of this family. 
In order to identify ligands for ROR-C, we performed 
ligand-binding studies. Membranes prepared from COS- 
7 cells tranfected with the ROR-C cDNA showed no 
specific binding activity for opioid ligands [24] includ- 
ing [u-Ala*, u-Leu’lenkephalin, [u-Ala*, MePhe4, Gly- 
ol’lenkephalin, [o-penicillamine*, u-penicillamine’l- 
enkephalin, ethylketocyclazocine, U69,593, bremazoc- 
ine, naloxone and naltrindole. We also tested ligands for 
the sigma receptors including haloperidol, SKF- 10,047 
and 1,3-di-0-tolylguanidine, because these receptors 
were originally classified as a subtype of the opioid re- 
ceptors [25] and could be expected to have high amino 
acid sequence homology with the opioid receptors. How- 
ever, no specific binding of sigma ligands could be de- 
tected for membranes prepared from COS-7 cells trans- 
fected with the ROR-C cDNA. 
Poly(A)+ RNA preparations from rat tissues were sub- 
jected to blot hybridization analysis (Fig. 3a). Cerebrum 
and brainstem contain three RNA species of - 15.5 kilo- 
bases (kb), -8.8 kb and -3.7 kb hybridizable with the 
ROR-C cDNA probe; the multiple RNA species may 
arise from polyadenylation at different sites and/or from 
alternative splicing. A very small amount of ROR-C 
mRNA is detectable in cerebellum. No signal is observed 
for kidney. Blot hybridization analysis of total RNA 
isolated from various regions of rat brain (Fig. 3b) shows 
that a moderate amount of the - 15.5-kb RNA species 
hybridizable with the ROR-C cDNA probe is present in 
hypothalamus and brainstem and small amount in thala- 
mus and cerebral cortex. No signal is detectable in spinal 
cord, olfactory bulb, caudate-putamen, hippocampus 
and cerebellum. 
Next we analyzed rat brain tissues for ROR-C mRNA 
by in situ hybridization with riboprobes (Fig. 4). Consis- 
tent with the result obtained by RNA blot hybridization 
analysis (see above), brainstem and forebrain are found 
to contain specific hybridization signals in discrete cell 
groups. In brainstem, high expression is localized to nu- 
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Fig. 3. Autoradiograms of blot hybridization analysis of poly(A)’ RNA 
(a) and total RNA (b) from rat tissues with the probe derived from the 
ROR-C cDNA. (a) Each lane contains 30 ,ug of poly(A)’ RNA; lanes: 
1, kidney; 2, cerebellum; 3, brainstem; and 4, cerebrum. The size mark- 
ers are indicated in kb. (b) Each lane contains 30 ,&g of total RNA; 
lanes: 1, spinal cord; 2, olfactory bulb; 3, hypothalamus; 4, thalamus; 
5, caudate-putamen; 6, hippocampus; 7, brainstem; 8, cerebellum; and 
9, cerebral cortex. The -15.5-kb RNA species hybridizable with the 
ROR-C cDNA probe is shown. 
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Fig. 4. In situ hybridization analysis of rat brainstem (a and d) and hypothalamus (b, c and e) using the digoxigenin-labelled antisense (a, b, d and 
e) and sense (c) riboprobes for ROR-C. Bright field photomicrographs how signal-containing cells in the locus coeruleus (LC; a and d), the 
ventromedial nucleus of hypothalamus (VMH; b and e), and the paraventricular nucleus of hypothalamus (PVH; b). In brainstem (a and d), some 
hybridization-positive cells are also observed in the parabrachial nucleus (PB; d). Hybridization with the sense riboprobe (c) reveals no appreciable 
labelling in VMH and PVH. 3V, third ventricle; 4V, fourth ventricle. Scale bars = 500 p (a-c), 50 p (d and e). 
merous neurons in the locus coeruleus and also to some 
neurons scattered in the parabrachial nucleus (Fig. 4a 
and d). In forebrain, high expression is observed in two 
hypothalamic nuclei, the ventromedial nucleus and the 
paraventricular nucleus (Fig. 4b and e). The hybridiza- 
tion signal in these hypothalamic nuclei is weaker than 
that found in the brainstem nuclei. In the paraventricular 
nucleus, neurons expressing ROR-C mRNA have small 
cell bodies and are localized to its dorsomedial portion. 
A sense riboprobe failed to yield specific hybridization 
signals in any of these brain sites (Fig. 4~). 
4. Discussion 
The primary structure of a novel member of the opioid 
receptor family, designated as ROR-C, has been deduced 
by cloning and sequencing the cDNA. Amino acid se- 
quence comparison reveals 51-53% identities between 
ROR-C and the members of the opioid receptor family 
including ROR-A, ROR-B and ROR-D. Although the 
close homology of the opioid receptor with the somato- 
statin receptor has been reported [5,7,12,15,16], the phy- 
logenetic tree shows that ROR-C can be classified as a 
member of the opioid receptor family rather than that of 
the somatostatin receptor family. From these observa- 
tions, we assumed that ROR-C might represent a 
G-protein-coupled receptor for opioid ligands or ligands 
closely related to opioids. However, our cDNA expres- 
sion studies could not detect any specific binding of 
opioid ligands or sigma ligands to ROR-C. Thus, ag- 
onists and antagonists for ROR-C remain to be identi- 
fied. 
RNA blot hybridization analysis showed that ROR-C 
mRNA is expressed in the rat central nervous system, 
predominantly in brainstem and hypothalamus. Fur- 
thermore, by in situ hybridization analysis, ROR-C 
mRNA was demonstrated to be expressed in neurons in 
the ventromedial nucleus and the paraventricular nu- 
cleus of hypothalamus, and in the locus coeruleus and 
the parabrachial nucleus in brainstem. Since 6-, p- and 
Fc-opioid receptor subtype mRNAs have been reported 
to be expressed in a variety of brain sites including hypo- 
thalamus and brainstem [6,11,13,14,26], comparison of 
our results with previous data may provide information 
as to the identification of ROR-C as a novel species of 
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the opioid receptor. The expression of &opioid receptor 
subtype mRNA is widespread in forebrain and the extent 
of expression in hypothalamus is broader than that 
shown here for ROR-C [ 111. The level of expression of 
p-opioid receptor subtype mRNA has been reported to 
be high in the locus coeruleus and the parabrachial nu- 
cleus, while the two hypothalamic nuclei seem to contain 
a negligible amount of A-opioid receptor subtype mRNA 
[ 131. The expression of g-opioid receptor subtype mRNA 
has more or less been shown in the ventromedial and 
paraventricular nuclei of hypothalamus and in the locus 
coeruleus as well as in several other brain sites [6,14,26]. 
Thus, the pattern of regional expression of the n-opioid 
receptor subtype is apparently closest to that of ROR-C 
mRNA. However, as shown in [6,26], hybridization sig- 
nals of the rc-opioid receptor subtype mRNA in the par- 
aventricular nucleus of hypothalamus appear to predom- 
inate over the more extensive region including the ven- 
trolateral or magnocellular portion, in contrast to the 
distribution pattern of ROR-C mRNA. Hence, the re- 
sults obtained by in situ hybridization analysis indicate 
that ROR-C has least similarities in regional expression 
of mRNA to any of the so far cloned opioid receptors. 
The locus coeruleus contains a great number of norad- 
renergic neurons; and the hypoth~amus is a center for 
regulation of the autonomic nervous system and the neu- 
roendocrine system. Therefore, the tissue distribution of 
ROR-C mRNA suggests that ROR-C may play a role in 
the modulation of neurotransmission i  the noradrener- 
gic system and/or in the regulation of the autonomic 
nervous system and the neuroendocrine system. 
During preparation of this manuscript, we learned 
that nucleotide sequences imilar to that of ROR-C have 
appeared in the Nucleotide Sequence Databases under 
the accession numbers U01913 and UO4952. 
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